Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""COVID-19 Vaccines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 4438
Tytuł:
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac.
Autorzy:
Ng HY; School of Clinical Medicine, The University of Hong Kong, Hong Kong.
Liao Y; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Zhang R; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Chan KH; Department of Microbiology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
To WP; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Hui CH; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Seto WK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Leung WK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Hung IFN; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Lam TTY; State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong.; Centre for Immunology & Infection Ltd., 17W Hong Kong Science & Technology Parks, Hong Kong.; Laboratory of Data Discovery for Health Ltd., 19W Hong Kong Science & Technology Parks, Hong Kong.; School of Public Health, The University of Hong Kong, Hong Kong.
Cheung KS; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
COVID-19 Vaccines*
Vaccines, Inactivated*
Humans ; Male ; Middle Aged ; Prospective Studies ; Adenosine ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.
Autorzy:
Yousefi Adlsadabad S; Department of Chemistry, McGill University, 801 Sherbrooke St West, Montreal, QC H3A 0B8, Canada.
Hanrahan JW; Department of Physiology, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC H3G 1Y6, Canada.
Kakkar A; Department of Chemistry, McGill University, 801 Sherbrooke St West, Montreal, QC H3A 0B8, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19 Vaccines*
Nanoparticles*
Humans ; Lipids ; Polymers ; RNA, Messenger/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
Autorzy:
Heftdal LD; Viro-Immunology Research Unit, Department of Infectious Diseases, Section 8632, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.; Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaloees Vej 5, 2200 Copenhagen N, Denmark.
Hansen CB; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Ole Maaloees Vej 26, 2200 Copenhagen N, Denmark.
Hamm SR; Viro-Immunology Research Unit, Department of Infectious Diseases, Section 8632, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Pérez-Alós L; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Ole Maaloees Vej 26, 2200 Copenhagen N, Denmark.
Fogh K; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.; Department of Emergency Medicine, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Pries-Heje M; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Hasselbalch RB; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.; Department of Emergency Medicine, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.
Møller DL; Viro-Immunology Research Unit, Department of Infectious Diseases, Section 8632, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Gang AO; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Ostrowski SR; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.; Department of Clinical Immunology, Section 2034, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Frikke-Schmidt R; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Sørensen E; Department of Clinical Immunology, Section 2034, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Hilsted L; Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Bundgaard H; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Ole Maaloees Vej 26, 2200 Copenhagen N, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Iversen K; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.; Department of Emergency Medicine, Copenhagen University Hospital, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 11, 2730 Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Sabin C; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, UCL, Royal Free Campus, Rowland Hill St, London NW3 2PF, UK.
Nielsen SD; Viro-Immunology Research Unit, Department of Infectious Diseases, Section 8632, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.; Department of Surgical Gastroenterology and Transplantation, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.
Grønbæk K; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark.; Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaloees Vej 5, 2200 Copenhagen N, Denmark.; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Dec 20; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
Leukemia, Lymphocytic, Chronic, B-Cell*
Humans ; BNT162 Vaccine ; Immunity, Humoral ; Vaccination ; Antibodies, Neutralizing ; Immunoglobulin G ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines.
Autorzy:
Soffritti I; Department of Chemical, Pharmaceutical and Agricultural Sciences, and Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.
D'Accolti M; Department of Chemical, Pharmaceutical and Agricultural Sciences, and Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.
Bini F; Department of Chemical, Pharmaceutical and Agricultural Sciences, and Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.
Mazziga E; Department of Chemical, Pharmaceutical and Agricultural Sciences, and Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.
Proietto D; Department of Chemical, Pharmaceutical and Agricultural Sciences, Laboratory of Biochemistry, Immunology and Microbiology (BIM), University of Ferrara, 44123 Ferrara, Italy.
Dallan B; Department of Chemical, Pharmaceutical and Agricultural Sciences, Laboratory of Biochemistry, Immunology and Microbiology (BIM), University of Ferrara, 44123 Ferrara, Italy.
Laurentis M; Department of Chemical, Pharmaceutical and Agricultural Sciences, Laboratory of Biochemistry, Immunology and Microbiology (BIM), University of Ferrara, 44123 Ferrara, Italy.
Ghisellini S; Laboratory of Clinical Pathology, University Hospital St. Anna, 44121 Ferrara, Italy.
Nicoli F; Department of Chemical, Pharmaceutical and Agricultural Sciences, Laboratory of Biochemistry, Immunology and Microbiology (BIM), University of Ferrara, 44123 Ferrara, Italy.
Caselli E; Department of Chemical, Pharmaceutical and Agricultural Sciences, and Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 25; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; BNT162 Vaccine ; 2019-nCoV Vaccine mRNA-1273 ; SARS-CoV-2 ; Immunization ; Antibodies, Viral ; mRNA Vaccines ; Immunoglobulin A
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination.
Autorzy:
Li D; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Pavlovitch-Bedzyk AJ; Computational and Systems Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Ebinger JE; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Khan A; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Hamideh M; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Merchant A; Cedars-Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Figueiredo JC; Cedars-Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Cheng S; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Davis MM; Computational and Systems Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Microbiology and Immunology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
McGovern DPB; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Melmed GY; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Xu AM; Cedars-Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Braun J; Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 18; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; SARS-CoV-2 ; Binding Sites, Antibody ; Tumor Necrosis Factor Inhibitors ; CD8-Positive T-Lymphocytes ; Vaccination ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.
Autorzy:
Gordeychuk IV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 117418 Moscow, Russia.
Kozlovskaya LI; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 117418 Moscow, Russia.
Siniugina AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Yagovkina NV; Kirov State Medical University of the Ministry of Health of Russia, 610998 Kirov, Russia.
Kuzubov VI; Healthcare Unit No. 163 of Federal Medical Biological Agency of Russia, 630559 Novosibirsk Region, Russia.
Zakharov KA; Eco-Safety Scientific Research Center, 196143 Saint-Petersburg, Russia.
Volok VP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.; Lomonosov Moscow State University, 119991 Moscow, Russia.
Dodina MS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Gmyl LV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Korotina NA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Theodorovich RD; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Ulitina YI; RIC-Pharma, 123298 Moscow, Russia.
Vovk DI; RIC-Pharma, 123298 Moscow, Russia.
Alikova MV; RIC-Pharma, 123298 Moscow, Russia.
Kataeva AA; RIC-Pharma, 123298 Moscow, Russia.
Kalenskaya AV; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Solovjeva IV; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Tivanova EV; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Kondrasheva LY; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Ploskireva AA; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Akimkin VG; Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123 Moscow, Russia.
Subbotina KA; Perm State Medical University named after E. A. Wagner of the Ministry of Healthcare of the Russian Federation, 614000 Perm, Russia.
Ignatyev GM; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Korduban AK; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Shustova EY; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Bayurova EO; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Zhitkevich AS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Avdoshina DV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Piniaeva AN; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Kovpak AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Antonova LP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Rogova YV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Shishova AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 117418 Moscow, Russia.
Ivin YY; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Sotskova SE; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Chernov KA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Ipatova EG; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Korduban EA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.
Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 117418 Moscow, Russia.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 29; Vol. 15 (9). Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*/adverse effects
COVID-19*/prevention & control
Humans ; Middle Aged ; Aged ; Vaccines, Attenuated ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers.
Autorzy:
Reinkemeyer C; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Khazaei Y; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.
Weigert M; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.; Munich Center for Machine Learning (MCML), 80539 Munich, Germany.
Hannes M; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Le Gleut R; Institute of Computational Biology, Helmholtz Munich, 85764 Neuherberg, Germany.; Core Facility Statistical Consulting, Helmholtz Munich, 85764 Neuherberg, Germany.
Plank M; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Winter S; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Noreña I; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Meier T; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.
Xu L; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.
Rubio-Acero R; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Wiegrebe S; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.; Department of Genetic Epidemiology, University of Regensburg, 93053 Regensburg, Germany.
Le Thi TG; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstrasse 4, 80337 Munich, Germany.
Fuchs C; Institute of Computational Biology, Helmholtz Munich, 85764 Neuherberg, Germany.; Core Facility Statistical Consulting, Helmholtz Munich, 85764 Neuherberg, Germany.; Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany.; Center for Mathematics, Technische Universität München, 85748 Garching, Germany.
Radon K; Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany.; Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany.; Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 89337 Munich, Germany.
Paunovic I; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Janke C; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
Wieser A; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany.; Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, 80336 Munich, Germany.
Küchenhoff H; Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigstraße 33, 80539 Munich, Germany.
Hoelscher M; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.; Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany.
Castelletti N; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany.; Institute of Radiation Medicine, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Pokaż więcej
Corporate Authors:
KoCo-Impf/ORCHESTRA working group
Źródło:
Viruses [Viruses] 2023 Jul 18; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Seroepidemiologic Studies ; SARS-CoV-2 ; Risk Factors ; Health Personnel ; Immunity ; Immunization ; Antibodies, Viral ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review.
Autorzy:
Tavazzi E; IRCCS Mondino Foundation, 27100 Pavia, Italy.
Pichiecchio A; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
Colombo E; IRCCS Mondino Foundation, 27100 Pavia, Italy.
Rigoni E; IRCCS Mondino Foundation, 27100 Pavia, Italy.
Asteggiano C; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
Vegezzi E; IRCCS Mondino Foundation, 27100 Pavia, Italy.
Masi F; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
Greco G; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
Bastianello S; Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
Bergamaschi R; IRCCS Mondino Foundation, 27100 Pavia, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 18; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Multiple Sclerosis*
Humans ; SARS-CoV-2 ; Viral Vaccines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
Autorzy:
Martora F; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Battista T; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Ruggiero A; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Scalvenzi M; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Villani A; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Megna M; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Potestio L; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 23; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Humans ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; Vaccination/adverse effects ; Viral Vaccines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues.
Autorzy:
Banoun H; Independent Researcher, 13001 Marseille, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 22; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Female ; Humans ; Male ; Genetic Therapy/adverse effects ; RNA, Messenger/genetics ; Semen ; Tissue Distribution ; Vaccines/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?
Autorzy:
Cocco N; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Leibundgut G; University Heart Center, University Hospital Basel, Petersgraben 4, 4053 Basel, Switzerland.
Pelliccia F; Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, 00186 Rome, Italy.
Cammalleri V; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Nusca A; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Mangiacapra F; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Cocco G; Unit of Ultrasound in Internal Medicine, Department of Medicine and Aging Sciences, University of Chieti G d'Annunzio, 65122 Chieti, Italy.
Fanale V; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Ussia GP; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Grigioni F; Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 20; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Drug-Related Side Effects and Adverse Reactions*
Humans ; Arrhythmias, Cardiac/etiology ; SARS-CoV-2 ; Vaccination/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register-12-Month Follow-Up.
Autorzy:
Babicki M; Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.
Kapusta J; Department of Internal Diseases, Rehabilitation and Physical Medicine, Medical University of Lodz, 90-647 Lodz, Poland.
Pieniawska-Śmiech K; Department of Immunology and Pediatrics, The J. Gromkowski Provincial Specialist Hospital, 51-149 Wroclaw, Poland.; Department of Clinical Immunology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Kałuzińska-Kołat Ż; Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.; Boruta Medical Center, 95-100 Zgierz, Poland.
Kołat D; Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.; Boruta Medical Center, 95-100 Zgierz, Poland.
Mastalerz-Migas A; Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.
Jankowski P; Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.
Chudzik M; Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 13; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Follow-Up Studies ; Post-Acute COVID-19 Syndrome ; Retrospective Studies ; SARS-CoV-2 ; Vaccination ; Headache
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants.
Autorzy:
Yahalom-Ronen Y; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Tamir H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Melamed S; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Politi B; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Achdout H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Erez N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Israeli O; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Cohen-Gihon I; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Chery Mimran L; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Barlev-Gross M; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Mandelboim M; Central Virology Laboratory, Ministry of Health, Sheba Medical Center, Tel Hashomer, Ramat Gan 76100, Israel.
Orr I; Bioinformatics Unit, Life Science Core Facilities, Weizmann Institute of Science, Rehovot 52621, Israel.
Feldmesser E; Bioinformatics Unit, Life Science Core Facilities, Weizmann Institute of Science, Rehovot 52621, Israel.
Weiss S; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Beth-Din A; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Paran N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Israely T; Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 13; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*
Animals ; Humans ; Mice ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice.
Autorzy:
Luan N; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Cao H; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Wang Y; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Lin K; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Hu J; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Liu C; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 11; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Animals ; Mice ; Humans ; SARS-CoV-2/genetics ; Cross Protection ; RNA, Messenger/genetics ; mRNA Vaccines ; Antibodies, Viral ; Antibodies, Neutralizing
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine.
Autorzy:
Seo YB; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Ko A; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Shin D; Research Institute, Genexine Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Kim J; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Suh YS; Research Institute, Genexine Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Na J; Research Institute, Genexine Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Ryu JI; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Lee S; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Oh MJ; Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
Sung YC; Research Institute, Genexine Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.; Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 05; Vol. 24 (11). Date of Electronic Publication: 2023 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*
T-Lymphocytes*
Animals ; Humans ; Mice ; Antibodies, Neutralizing ; Antibodies, Viral ; DNA ; RNA, Messenger/genetics ; SARS-CoV-2 ; Vaccination ; Vaccines, Inactivated ; Interferon-gamma/immunology ; Interferon-gamma/metabolism ; mRNA Vaccines
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy.
Autorzy:
Cortese P; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy.
Amato F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Davino A; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy.
De Franchis R; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy.
Esposito S; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Zollo I; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Di Domenico M; Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, 80138 Naples, Italy.
Solito E; Centre for Translational Medicine and Therapeutics William Harvey Research Institute, Queen Mary Univesity, London E1 4NS, UK.
Zarrilli F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Gentile L; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Cernera G; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Castaldo G; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2023 May 23; Vol. 12 (11). Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; BNT162 Vaccine ; Leukocytes, Mononuclear ; Tumor Necrosis Factor-alpha ; SARS-CoV-2 ; Pediatricians ; Italy ; Immunity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay.
Autorzy:
Orlandi C; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.; Laboratorio Covid, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Stefanetti G; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Barocci S; Department of Clinical Pathology, Azienda Sanitaria Unica Regionale Marche Area Vasta 1 (ASUR Marche AV1), Viale Comandino 70, 61029 Urbino, PU, Italy.
Buffi G; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Diotallevi A; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Rocchi E; Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, BO, Italy.
Ceccarelli M; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Peluso S; Department of Physics and Astronomy, University of Bologna, Viale Berti Pichat 6/2, 40127 Bologna, BO, Italy.
Vandini D; Department of Clinical Pathology, Azienda Sanitaria Unica Regionale Marche Area Vasta 1 (ASUR Marche AV1), Viale Comandino 70, 61029 Urbino, PU, Italy.
Carlotti E; Department of Prevention, ASUR Marche AV1, Viale Comandino 21, 61029 Urbino, PU, Italy.
Magnani M; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.; Laboratorio Covid, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Galluzzi L; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Casabianca A; Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.; Laboratorio Covid, University of Urbino Carlo Bo, Via Arco d'Augusto 2, 61032 Fano, PU, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 13; Vol. 15 (5). Date of Electronic Publication: 2023 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; Longitudinal Studies ; BNT162 Vaccine ; SARS-CoV-2 ; Vaccination ; ChAdOx1 nCoV-19 ; Immunoglobulin G ; Antibodies, Viral ; Antibodies, Neutralizing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant.
Autorzy:
Del Mastro A; AORN A. Cardarelli-Internal Medicine Division 1-Immunology Unit, 80131 Naples, Italy.
Picascia S; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
D'Apice L; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
Trovato M; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
Barba P; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
Di Biase I; MeriGen Diagnostic&C, SAS, 80131 Naples, Italy.
Di Biase S; MeriGen Diagnostic&C, SAS, 80131 Naples, Italy.
Laccetti M; AORN A. Cardarelli-Internal Medicine Division 1-Immunology Unit, 80131 Naples, Italy.
Belli A; AORN A. Cardarelli-Clinical Pathology Division, 80131 Naples, Italy.
Amato G; AORN A. Cardarelli-Clinical Pathology Division, 80131 Naples, Italy.
Di Muro P; AORN A. Cardarelli-Nephrology and Dialysis Unit, 80131 Naples, Italy.
Credendino O; AORN A. Cardarelli-Nephrology and Dialysis Unit, 80131 Naples, Italy.
Picardi A; AORN A. Cardarelli-Molecular Biology Laboratory-Hematology and HSC Transplantation Unit, 80131 Naples, Italy.
De Berardinis P; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
Del Pozzo G; Institute of Genetics and Biophysics, Italian National Council of Research, 80131 Naples, Italy.
Gianfrani C; Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 09; Vol. 15 (5). Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; BNT162 Vaccine ; SARS-CoV-2/genetics ; Antibodies, Neutralizing ; Kidney ; Antibodies, Viral ; mRNA Vaccines
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL.
Autorzy:
Ciesielka, Jakub (AUTHOR)
Jakimów, Krzysztof (AUTHOR)
Tekiela, Natalia (AUTHOR)
Peisert, Laura (AUTHOR)
Kwaśniewska, Anna (AUTHOR)
Kata, Dariusz (AUTHOR)
Chudek, Jerzy (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 5, p1263. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 4438

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies